Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $2.90 USD
Change Today -0.06 / -2.03%
Volume 1.3M
IDRA On Other Exchanges
As of 8:10 PM 09/3/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

William S. Reardon CPA

Lead Director, Chairman of Audit Committee and Member of Nominating & Corporate Governance Committee,Idera Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 53 board members in 6 different organizations across 8 different industries.

See Board Relationships


Mr. William S. Reardon, CPA served as the Business Assurance Audit Partner at PricewaterhouseCoopers LLP's Boston office and leader of its life sciences industry practice for New England and the eastern U.S from 1986 to July 2002. Mr. Reardon retired from PricewaterhouseCoopers LLP, where he was employed from June 1973 to July 2002. He has been Director of Synta Pharmaceuticals Corp. since August 2004. He has been a Director for Idera Pharmaceuticals, Inc. since 2002 ...

Read Full Background

Corporate Headquarters*

167 Sidney Street
Cambridge, Massachusetts 02139

United States

Phone: 617-679-5500
Fax: 617-679-5592

Board Members Memberships*

Lead Director, Chairman of Audit Committee and Member of Nominating & Corporate Governance Committee
Director and Chairman of Audit Committee
Trustee, Chairman of Qualified Legal Compliance Committee, Member of Valuation Committee and Member of Audit Committee
Independent Trustee, Chairman of Qualified Legal Compliance Committee, Member of Audit Committee and Member of Valuation Committee


Harvard University
Harvard College

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

Exercisable Options47,000
Unexercisable Options5,000
Total Number of Options52,000

Total Compensation*

Total Annual Cash Compensation$35,000
Total Calculated Compensation$88,472
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IDRA:US $2.90 USD -0.06


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IDERA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at